AD-MSCs exhibit greater proliferative rates and trophic factor secretion (e.g., HGF, VEGF) compared to other MSC types, which may amplify their therapeutic effects in inflammatory and ischemic environments [41,44,45,46]. The gene discussed is VEGFA; the disease is Alzheimer disease.